Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Concomitant Methotrexate on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active Psoriasis Arthritis

NCT03148860 is registered in ClinicalTrials.gov with Dr. Frank Behrens as lead sponsor.

NCT NCT03148860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03148860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Concomitant Methotrexate on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active Psoriasis Arthritis
Lead sponsor
Dr. Frank Behrens
Phase
Phase 3
Overall status
Completed
Start date
December 15, 2016
Completion date
October 21, 2021
Enrollment
186 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis